LIAISON Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study.
Fiche publication
Date publication
juillet 2022
Journal
United European gastroenterology journal
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Fiorino G, Danese S, Peyrin-Biroulet L, Sans M, Bonelli F, Calleri M, Zierold C, Pollastro R, Moretti F, Malesci A
Lien Pubmed
Résumé
Fecal calprotectin (FC) is established as a diagnostic marker to differentiate between inflammatory bowel diseases and non-inflammatory conditions. Furthermore, it may be effective in monitoring response to treatment, and to predict relapse during maintenance therapy.
Mots clés
algorithm, calprotectin, flare, inflammatory bowel disease, machine learning, relapse, ulcerative colitis
Référence
United European Gastroenterol J. 2022 07 4;: